Shadia A. Galal

1.0k citations

23 papers · 890 indexed · h-index 13

Co-authors: Hoda I. El Diwani Amira S. Abd El‐All Mohamed Abdallah Khaled H. Hegab Ahmed S. Abdelsamie Sean M. Kerwin Mamdouh M. Ali Fatma A.F. Ragab
Topics: Synthesis and biological activity (12 papers)Synthesis and Biological Evaluation (11 papers)Cancer therapeutics and mechanisms (4 papers)
Cited by: Organic Chemistry Toxicology Pharmaceutical Science
Journals: European Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry Bioorganic & Medicinal Chemistry Letters
Partner nations: Egypt United States Japan

In The Last Decade

Shadia A. Galal

22 papers receiving 864 citations

Peers

Countries citing papers authored by Shadia A. Galal

Since Specialization

Citations

This map shows the geographic impact of Shadia A. Galal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shadia A. Galal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shadia A. Galal more than expected).

Fields of papers citing papers by Shadia A. Galal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shadia A. Galal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shadia A. Galal. The network helps show where Shadia A. Galal may publish in the future.

Co-authorship network of co-authors of Shadia A. Galal

This figure shows the co-authorship network connecting the top 25 collaborators of Shadia A. Galal. A scholar is included among the top collaborators of Shadia A. Galal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shadia A. Galal. Shadia A. Galal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis, biological evaluation, and docking studies of pyrazole-linked benzothiazole hybrids as promising anti-TB agents 2024 ·Journal of Molecular Structure ·(unknown),(unknown),(unknown),Ahmed S. Abdelsamie,Marwa M. Abdel‐Aziz,Shadia A. Galal,Galal H. Elgemeie,Hoda I. El Diwani,Keith J. Flanagan,Mathias O. Senge	9
2	Design and synthesis of new pyrazolylbenzimidazoles as sphingosine kinase-1 inhibitors 2021 ·Medicinal Chemistry Research ·Shadia A. Galal,Mohamed A. Omar,(unknown),Fatma A.F. Ragab,Sonam Roy,Ahmad Abu Turab Naqvi,Md. Imtaiyaz Hassan,Hoda I. El Diwani	7
3	Part III: Novel checkpoint kinase 2 (Chk2) inhibitors; design, synthesis and biological evaluation of pyrimidine-benzimidazole conjugates 2018 ·European Journal of Medicinal Chemistry ·Shadia A. Galal,Muhammad Khattab,Samia A. Shouman,Raghda Ramadan,Omaima M. Kandil,Omnia M. Kandil,Ashraf A. Tabll,Yasmine S. El,Reem El‐Shenawy,Yasmin M. Attia,Ahmed A. El‐Rashedy,Hoda I. El Diwani	18
4	Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs 2017 ·European Journal of Medicinal Chemistry ·Shadia A. Galal,Ahmed S. Abdelsamie,Samia A. Shouman,Yasmin M. Attia,Hamed I. Ali,Ashraf A. Tabll,Reem El‐Shenawy,Yasmine S. El,Mamdouh M. Ali,Abeer E. Mahmoud,(unknown),(unknown),Adel S. Girgis,Hoda I. El Diwani	33
5	Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors 2016 ·Bioorganic & Medicinal Chemistry ·Shadia A. Galal,Muhammad Khattab,(unknown),Evangelia D. Chrysina,Jean‐Pierre Praly,Fatma A.F. Ragab,(unknown)	6
6	Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity 2014 ·European Journal of Medicinal Chemistry ·Shadia A. Galal,(unknown),Fatma A.F. Ragab,Ahmed S. Abdelsamie,Mamdouh M. Ali,(unknown),Jérémie Mortier,Gerhard Wolber,Hoda I. El Diwani	121
7	Design, synthesis and structure–activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor 2013 ·European Journal of Medicinal Chemistry ·Shadia A. Galal,Ahmed S. Abdelsamie,(unknown),Jérémie Mortier,Gerhard Wolber,Mamdouh M. Ali,Harukuni Tokuda,Nobutaka Suzuki,(unknown),Raghda Ramadan,Hoda I. El Diwani	39
8	Synthesis and docking studies of novel antitumor benzimidazoles 2012 ·Bioorganic & Medicinal Chemistry ·Mohamed A. Omar,Yasser M. Shaker,Shadia A. Galal,Mamdouh M. Ali,Sean M. Kerwin,Jing Li,Harukuni Tokuda,Raghda Ramadan,Hoda I. El Diwani	33
9	Different synthetic routes to 4-(1H-benzo[d]imidazol-2-yl)aniline 2012 ·Research on Chemical Intermediates ·Muhammad Khattab,Shadia A. Galal,Fatma A.F. Ragab,Hoda I. El Diwani	10
10	Synthesis, Characterization, and Cytotoxic Activity on MCF-7 Cell Line of Some Novel Metal Complexes With Substituted Benzimidazole Ligands 2012 ·Synthesis and Reactivity in Inorganic Metal-Organic and Nano-Metal Chemistry ·Ahmed M. A. El‐Seidy,(unknown),(unknown),Nabil S. Youssef,Shadia A. Galal,(unknown)	9
11	Novel Benzimidazo[2,1‐c][1,4]thiazinone Derivatives with Potent Activity Against HSV‐1 2011 ·Archiv der Pharmazie ·Shadia A. Galal,S Naem,Ahmed O. H. El‐Nezhawy,Mohamed A. Ali,Hoda I. El Diwani	10
12	ChemInform Abstract: Part 1. Synthesis, Cancer Chemopreventive Activity and Molecular Docking Study of Novel Quinoxaline Derivatives. 2011 ·ChemInform ·Shadia A. Galal,Ahmed S. Abdelsamie,Harukuni Tokuda,Nobutaka Suzuki,(unknown),Mahmoud ElHefnawi,Raghda Ramadan,(unknown),Hoda I. El Diwani	0
13	Synthesis and antitumor activity of novel benzimidazole-5-carboxylic acid derivatives and their transition metal complexes as topoisomerease II inhibitors 2010 ·European Journal of Medicinal Chemistry ·Shadia A. Galal,Khaled H. Hegab,Ahmed M. Hashem,Nabil S. Youssef	49
14	Novel antiviral benzofuran-transition metal complexes 2010 ·European Journal of Medicinal Chemistry ·Shadia A. Galal,Amira S. Abd El‐All,Khaled H. Hegab,(unknown),Nabil S. Youssef,Hoda I. El Diwani	47
15	Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives 2010 ·European Journal of Medicinal Chemistry ·Shadia A. Galal,Ahmed S. Abdelsamie,Harukuni Tokuda,Nobutaka Suzuki,(unknown),Mahmoud ElHefnawi,Raghda Ramadan,(unknown),Hoda I. El Diwani	63
16	Synthesis and studying the antitumor activity of novel 5-(2-methylbenzimidazol-5-yl)-1,3,4-oxadiazole-2(3H)-thiones 2010 ·European Journal of Chemistry ·Shadia A. Galal,Ahmed S. Abdelsamie,(unknown),Sean M. Kerwin,Hoda I. El Diwani	30
17	Synthesis of potent antitumor and antiviral benzofuran derivatives 2009 ·Bioorganic & Medicinal Chemistry Letters ·Shadia A. Galal,Amira S. Abd El‐All,Mohamed Abdallah,Hoda I. El Diwani	239
18	New Synthesis of Tetrahydrobenzo (4,5) Thieno (2,3d) Pyrimidine Derivatives and Schiff Bases Derived from 2-aminotetrahydro Benzothiophenes and Hetarylcarboxaldehydes Studies on Their Antitumor and Antimicrobial Activities 2009 ·(unknown),(unknown),Amira S. Abd El‐All,Shadia A. Galal	4
19	Synthesis and analgesic activity of (2,3-diphenyl-1H-indol-5-YL)piperazin-1-yl methanone derivatives 2009 ·Pharmaceutical Chemistry Journal ·Ahmed O. H. El‐Nezhawy,(unknown),Shadia A. Galal,Hoda I. El Diwani,Omar M. E. Abdel‐Salam,(unknown)	2
20	New transition metal ion complexes with benzimidazole-5-carboxylic acid hydrazides with antitumor activity 2008 ·European Journal of Medicinal Chemistry ·Shadia A. Galal,Khaled H. Hegab,(unknown),(unknown),Sean M. Kerwin,(unknown),Hoda I. El Diwani	115

About Shadia A. Galal

Shadia A. Galal is a scholar working on Organic Chemistry, Toxicology and Hepatology, having authored 23 papers that have together received 890 indexed citations. Recurring topics across this work include Synthesis and biological activity (12 papers), Synthesis and Biological Evaluation (11 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Organic Chemistry (755 citations), Toxicology (50 citations) and Pharmaceutical Science (80 citations). Shadia A. Galal has collaborated with scholars based in Egypt, United States and Japan. Frequent co-authors include Hoda I. El Diwani, Amira S. Abd El‐All, Mohamed Abdallah, Khaled H. Hegab, Ahmed S. Abdelsamie, Sean M. Kerwin, Mamdouh M. Ali, Fatma A.F. Ragab, Nabil S. Youssef and Gerhard Wolber. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact